Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Homology Medicines	Inozyme Pharma	ESSA Pharma	Rigel Pharmaceuticals	Akouos
Symbol	NASDAQ:FIXX	NASDAQ:INZY	NASDAQ:EPIX	NASDAQ:RIGL	NASDAQ:AKUS
Price Information
Current Price	$11.22	$21.93	$26.65	$4.37	$18.58
52 Week Range	Buy	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.7	1.7	1.1	1.6	1.7
Analysis Score	3.5	3.5	1.5	3.4	3.5
Community Score	2.5	2.8	3.1	2.8	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.8	1.7	1.7
Earnings & Valuation Score	0.6	0.6	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$30.43	$36.00	$24.50	$8.33	$33.00
% Upside from Price Target	171.20% upside	64.16% upside	-8.07% downside	90.69% upside	77.61% upside
Trade Information
Market Cap	$507.86 million	$512.57 million	$854.51 million	$738.45 million	$638.84 million
Beta	-0.24	N/A	1.96	1.48	N/A
Average Volume	331,924	68,164	483,644	4,194,268	116,460
Sales & Book Value
Annual Revenue	$1.67 million	N/A	N/A	$59.29 million	N/A
Price / Sales	304.11	N/A	N/A	12.45	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$5.73 per share	N/A	$2.47 per share	$0.32 per share	N/A
Price / Book	1.96	N/A	N/A	13.66	N/A
Profitability
Net Income	$-103,920,000.00	N/A	$-23,440,000.00	$-66,890,000.00	N/A
EPS	($2.47)	N/A	($1.04)	($0.40)	N/A
Trailing P/E Ratio	N/A	0.00	N/A	N/A	0.00
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-5,386.00%	N/A	N/A	-26.25%	N/A
Return on Equity (ROE)	-57.92%	N/A	-46.31%	-44.96%	N/A
Return on Assets (ROA)	-45.33%	N/A	-45.08%	-20.08%	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	0.39%	N/A
Current Ratio	10.55%	16.71%	66.75%	2.92%	37.39%
Quick Ratio	10.55%	16.71%	66.75%	2.86%	37.39%
Ownership Information
Institutional Ownership Percentage	75.20%	69.77%	63.37%	82.04%	88.70%
Insider Ownership Percentage	33.40%	N/A	N/A	4.72%	N/A
Miscellaneous
Employees	206	24	25	163	54
Shares Outstanding	45.26 million	23.37 million	32.06 million	168.98 million	34.38 million
Next Earnings Date	3/11/2021 (Estimated)	2/25/2021 (Estimated)	5/6/2021 (Estimated)	3/2/2021 (Confirmed)	2/25/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources